# Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

> **NCT04406246** · PHASE4 · COMPLETED · sponsor: **Materno-Perinatal Hospital of the State of Mexico** · enrollment: 150 (actual)

## Conditions studied

- Coronavirus Infection

## Interventions

- **DRUG:** Nitazoxanide 500Mg Oral Tablet

## Key facts

- **NCT ID:** NCT04406246
- **Lead sponsor:** Materno-Perinatal Hospital of the State of Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-21
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04406246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04406246, "Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04406246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*